Alector ALEC
NASDAQ ALEC
$2.46 -0.05 (-1.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alector (ALEC) Free Cash Flow (2018 - 2026)

Alector's (ALEC) quarterly Free Cash Flow came in at -$34.2 million in Q2 2026, up 30.19% year-over-year from -$26.3 million in Q2 2025, and up 31.41% quarter-over-quarter from -$49.9 million in Q1 2026.

Analysis

Alector (ALEC) Free Cash Flow (2018 - 2026) Analysis & Trends

Alector (ALEC) has reported Free Cash Flow for 9 consecutive years, with -$34.2 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Free Cash Flow rose 30.19% year-over-year to -$34.2 million in Q2 2026; TTM through Jun 2026 was -$158.4 million, a 26.67% increase from a year earlier, with the FY2025 full-year figure at -$184.1 million, up 20.37% from the prior year.
  • Free Cash Flow was -$34.2 million for Q2 2026 at Alector, up from -$49.9 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at $134.4 million in Q1 2022 and troughed at -$63.1 million in Q2 2024.
  • A 5-year average of -$39.5 million and a median of -$49.6 million in 2022 frame the typical range for Free Cash Flow.
  • Across the five-year window, Free Cash Flow soared 350.56% in 2022 and sank 136.88% in 2023, its largest moves.
  • Over 5 years, Free Cash Flow stood at -$49.7 million in 2022, then increased by 6.82% to -$46.3 million in 2023, then fell by 19.22% to -$55.2 million in 2024, then climbed by 24.47% to -$41.7 million in 2025, then grew by 17.85% to -$34.2 million in 2026.
  • The last three Free Cash Flow figures came in at -$34.2 million (Q2 2026), -$49.9 million (Q1 2026), and -$41.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 3.49 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 3.43 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 1.01 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 572.80 Mn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn -563.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 292.04 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 408.00 Mn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn -95.09 Mn
10 Alector 274.68 Mn 101.88 Mn - -34.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -34.25 Mn
Mar 31, 2026 -49.93 Mn
Dec 31, 2025 -41.69 Mn
Sep 30, 2025 -32.52 Mn
Jun 30, 2025 -49.06 Mn
Mar 31, 2025 -60.80 Mn
Dec 31, 2024 -55.20 Mn
Sep 30, 2024 -50.95 Mn
Jun 30, 2024 -63.13 Mn
Mar 31, 2024 -61.88 Mn
Dec 31, 2023 -46.30 Mn
Sep 30, 2023 -46.45 Mn
Jun 30, 2023 -44.22 Mn
Mar 31, 2023 -49.57 Mn
Dec 31, 2022 -49.69 Mn
Sep 30, 2022 -50.97 Mn
Jun 30, 2022 -58.19 Mn
Mar 31, 2022 134.40 Mn
Dec 31, 2021 -49.82 Mn
Sep 30, 2021 444.14 Mn